Perspectives In Aseptic Manufacturing: Protecting Your Drug Product: Integrating Engineering And Quality

By Eric Kurtz, Manager Technical Product Development

In aseptic fill/finish, product protection is not a single decision but the cumulative result of engineering choices made across the line. Written by Eric Kurtz, Manager of Technical Product Development, this article examines how inert gas purging strategies, plunger placement methods, dosing accuracy verification approaches, and barrier system design each carry distinct quality implications, and how they interact in ways that affect sterility assurance and regulatory confidence.

For oxygen-sensitive formulations, the choice between displacement methods and controlled vacuum and gas replacement chambers must account for airflow dynamics within the barrier system. Plunger insertion variables, including vacuum timing and final position, affect residual bubble size and contamination risk. Dosing verification strategies involve real tradeoffs between throughput and assurance levels. These are not isolated decisions. Each engineering choice influences the others, and alignment across packaging components, equipment capability, and contamination control strategy is what ultimately protects the drug product. Examine the full analysis to understand how these variables connect.